Gilgamesh Pharma

New York, NY · Founded 2019 · Privately Held (backing)

Developer of novel chemical entities designed to transform the treatment of psychiatric disorders through rapid-acting and durable therapies. Gilgamesh Pharma is based in New York, NY and was founded in 2019. Its last reported valuation was $189 million in May 2022. It has raised $136 million across 3 recorded rounds; the latest was a $2.3 million seed round in Mar 2026.

Last reported valuation
$188.5M
Oct 2026
Priced at
—
Total raised
$135.8M
Last round
Seed Round
Mar 2026

Who backs Gilgamesh Pharma?

24 investors
InvestorType
Y CombinatorOther
Alumni VenturesVenture capital
Pioneer FundVenture capital
Offline VenturesVenture capital
What If VenturesVenture capital
Prime Movers LabVenture capital
Aera VCVenture capital
Satori CapitalPE / buyout
Seven Hound VenturesFund of funds
10X Capital—
+ 14 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Gilgamesh Pharma investors

24 investors are on record for Gilgamesh Pharma, including Y Combinator, Alumni Ventures, Pioneer Fund and Offline Ventures. By type, the record holds 6 venture capital firms, 1 private equity firm and 1 fund of funds. The seed round in Mar 2026 drew 3 investors.

Free account
More of Gilgamesh Pharma with a free account
  • ·The complete investor list: 24 names
  • ·Watch Gilgamesh Pharma: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 24 firms already write checks for companies like Gilgamesh Pharma. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View